While deep learning has achieved great success in computer vision and many other fields, currently it does not work very well on patient genomic data with the “big p, small N” problem (i.e., a relatively small number of samples with highdimensional features). In order to make deep learning work with a small amount of training data, we have to design new models that facilitate few-shot learning. Here we present the Affinity Network Model (AffinityNet), a data efficient deep learning model that can learn from a limited number of training examples and generalize well. The backbone of the AffinityNet model consists of stacked k-Nearest-Neighbor (kNN) attention pooling layers. The kNN attention pooling layer is a generalization of the Graph Atte...
We propose a novel attention gate (AG) model for medical image analysis that automatically learns to...
Despite the vast increase of high-throughput molecular data, the prediction of important disease gen...
The discovery of new hits through ligand-based virtual screening in drug discovery is essentially a ...
Few-shot learning presents a challenging paradigm for training discriminative models on a few traini...
The use of high-throughput omics technologies is becoming increasingly popular in all facets of biom...
The performance of deep learning methods is heavily dependent on the quality of data representations...
While Deep Learning methods have been successfully applied to tackle a wide variety of prediction pr...
Contemporary deep learning approaches exhibit state-of-the-art performance in various areas. In heal...
In recent years, deep learning has made a significant impact in various fields – helping to push the...
Few-shot learning aims to learn novel categories from very few samples given some base categories wi...
Graph-based neural network models are gaining traction in the field of representation learning due t...
Recent years have brought progress in the graph machine learning space, with the unsupervised graph...
Background: Contemporary deep learning approaches show cutting-edge performance in a variety of comp...
This thesis addresses and investigates the recent development of graph attention network (GAT) model...
Deep learning has attracted tremendous attention from researchers in various fields of information e...
We propose a novel attention gate (AG) model for medical image analysis that automatically learns to...
Despite the vast increase of high-throughput molecular data, the prediction of important disease gen...
The discovery of new hits through ligand-based virtual screening in drug discovery is essentially a ...
Few-shot learning presents a challenging paradigm for training discriminative models on a few traini...
The use of high-throughput omics technologies is becoming increasingly popular in all facets of biom...
The performance of deep learning methods is heavily dependent on the quality of data representations...
While Deep Learning methods have been successfully applied to tackle a wide variety of prediction pr...
Contemporary deep learning approaches exhibit state-of-the-art performance in various areas. In heal...
In recent years, deep learning has made a significant impact in various fields – helping to push the...
Few-shot learning aims to learn novel categories from very few samples given some base categories wi...
Graph-based neural network models are gaining traction in the field of representation learning due t...
Recent years have brought progress in the graph machine learning space, with the unsupervised graph...
Background: Contemporary deep learning approaches show cutting-edge performance in a variety of comp...
This thesis addresses and investigates the recent development of graph attention network (GAT) model...
Deep learning has attracted tremendous attention from researchers in various fields of information e...
We propose a novel attention gate (AG) model for medical image analysis that automatically learns to...
Despite the vast increase of high-throughput molecular data, the prediction of important disease gen...
The discovery of new hits through ligand-based virtual screening in drug discovery is essentially a ...